ACOU.ST

Healthcare Biotechnology

AcouSort AB (publ)

SEK 3.27
-0.31 -8.66% today

Price History

Not enough data

Key Stats

Market Cap
69.21M
Avg Volume
26,460
EPS
-SEK 0.52
52W High
SEK 5.16
52W Low
SEK 2.03
Div. Yield
0.0%

Valuation

Forward P/E
-4.09
P/B Ratio
7.06
P/S Ratio
7.43
EV/EBITDA
-5.70
EV/Revenue
7.12

Margins

Gross Margin 97.3%
Operating Margin (168.7%)
Net Margin (120.5%)
EBITDA Margin (124.9%)

Growth & Returns

Revenue Growth (YoY)
(25.6%)
Return on Equity
(72.3%)
Return on Assets
(30.8%)

Liquidity & Leverage

Current Ratio
1.41
Quick Ratio
1.07
Total Cash
9.48M
Total Debt
0

About

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, a module that enables in-line analysis of blood plasma from whole blood samples; Acoustic Separation Module, a microfluidic solution that provides continuous separation, washing or up-concentration of cells; Acoustic Trapping Module, a microfluidic cell sorters or quality control systems for bioreactors and cell therapy production; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has a collaboration agreement with Moeller Medical to exhibit a prototype system for analyzing separation of cells from body fluids. AcouSort AB (publ) was incorporated in 2010 and is based in Lund, Sweden.

www.acousort.com